We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,822
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Salesforce
CRM
$155B
| $74.5M | 0.39% |
274,534
+33,435
| +14% | +$8.49M |
|
52
Oracle
ORCL
$417B
| $74.4M | 0.39% |
853,996
+43,108
| +5% | +$3.81M |
|
53
Comcast
CMCSA
$87.4B
| $73.9M | 0.39% |
1,322,126
+67,287
| +5% | +$3.92M |
|
54
Chevron
CVX
$380B
| $73.9M | 0.39% |
728,871
+78,883
| +12% | +$7.87M |
|
55
Vanguard FTSE Developed Markets ETF
VEA
$233B
| $73.8M | 0.39% |
1,462,079
+304,866
| +26% | +$15.9M |
|
56
Intel
INTC
$499B
| $73.3M | 0.39% |
1,375,999
+64,197
| +5% | +$3.48M |
|
57
Micron Technology
MU
$995B
| $73M | 0.38% |
1,028,786
+58,790
| +6% | +$4.41M |
|
58
Coherent
COHR
$63.2B
| $69.9M | 0.37% |
1,176,859
+225,590
| +24% | +$14.7M |
|
59
Verizon
VZ
$193B
| $69.2M | 0.36% |
1,282,183
+81,701
| +7% | +$4.52M |
|
60
Danaher
DHR
$136B
| $68M | 0.36% |
252,140
+17,775
| +8% | +$4.84M |
|
61
iShares Core S&P 500 ETF
IVV
$894B
| $66.7M | 0.35% |
154,910
+11,871
| +8% | +$5.26M |
|
62
PepsiCo
PEP
$189B
| $66.6M | 0.35% |
442,569
-867
| -0.2% | -$134K |
|
63
Nike
NKE
$62.1B
| $66.3M | 0.35% |
456,408
+59,227
| +15% | +$9.66M |
|
64
SPDR Gold Trust
GLD
$132B
| $65.8M | 0.35% |
400,468
+46,632
| +13% | +$7.81M |
|
65
Honeywell
HON
$78.6B
| $65.7M | 0.35% |
328,587
+20,081
| +7% | +$4.28M |
|
66
ResMed
RMD
$31.5B
| $65.3M | 0.34% |
247,790
-17,771
| -7% | -$4.86M |
|
67
Adobe
ADBE
$101B
| $62.2M | 0.33% |
108,050
+11,611
| +12% | +$7.31M |
|
68
Vanguard Total World Stock ETF
VT
$78.8B
| $62.1M | 0.33% |
609,855
+83,973
| +16% | +$8.8M |
|
69
NextEra Energy
NEE
$179B
| $61.7M | 0.32% |
785,773
+62,855
| +9% | +$5.07M |
|
70
Vanguard Information Technology ETF
VGT
$146B
| $60.7M | 0.32% |
1,211,048
+58,816
| +5% | +$3.05M |
|
71
Alnylam Pharmaceuticals
ALNY
$29B
| $60.1M | 0.32% |
318,100
-79,209
| -20% | -$14.9M |
|
72
Broadcom
AVGO
$1.96T
| $59.6M | 0.31% |
1,229,780
+193,550
| +19% | +$9.41M |
|
73
TSMC
TSM
$2.15T
| $54.2M | 0.28% |
485,288
+21,434
| +5% | +$2.52M |
|
74
Starbucks
SBUX
$118B
| $53.6M | 0.28% |
485,946
+72,724
| +18% | +$8.51M |
|
75
Mastercard
MA
$501B
| $53.4M | 0.28% |
153,684
+2,295
| +2% | +$835K |
|
Similar funds
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,822 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.